The Radiation Oncology Poster Platform

A Phase I, Open-Label, Dose Escalation Study (EGF100262) of Lapatinib Plus Chemoradiation in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

<< Back
Title: A Phase I, Open-Label, Dose Escalation Study (EGF100262) of Lapatinib Plus Chemoradiation in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Authors: Iman El-Hariry 1, Kevin Harrington 2, Jean Bourhis 3, Clare Holford 1 1Oncology MDC Clinical Development, GlaxoSmithKline R&D, Greenford, United Kingdom; 2Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom; 3Department of Radiation Oncology, Institut Gustave-Roussy, Paris, France.
Presenter: El-Hariri Iman - Contact
Category: Head/Neck
Language: English
Download link: View this poster
Date of Validation: 2008-04-08